HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health, Beauty And Wellness News: ByOM, Premier, Frutarom, Lactalis

This article was originally published in The Rose Sheet

Executive Summary

New Chapter founders onto next chapter; French dairy firm acquires African pharma's formula business; 'Earth First' packaging for Premier Protein shakes; and Frutarom touts cognitive ingredient award for Neuravena.

You may also be interested in...



Skin Care Line First For New Chapter Founder Schulick, Nutraceuticals In 2020

New Chapter founder Paul Schulick will introduce skin masks, cleansers and lotions with Algatech's topical astaxanthin to maintain skin microbiome. He also plans to launch nutraceuticals once a non-compete agreement with P&G, the owner of his former firm New Chapter, expires in 2020.

New Chapter Founders' Vision Limited, Voice Stifled Under Parent Firm P&G

New Chapter founders Paul and Barbi Schulick leave and sever ties with parent firm Procter & Gamble six years after their company providing herbal products to US health food and vitamin stores was acquired by the global consumer health, personal and household care products marketer. Nature's Bounty adds Don Kerrigan, formerly in charge of US OTC drug marketing for Bayer and Pfizer, as its president for North America.

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Topics

Related Companies

UsernamePublicRestriction

Register

RS121832

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel